Grant: Banting Postdoctoral Fellowship Program
Direct Payment
$140,000.00
The role of myofilament mechanics and calcium handling in the pathogenesis of hypertrophic cardiomyopathy
EF 2013-14
Résumé
Hypertrophic cardiomyopathy (HCM) is a genetic disorder of heart muscle and affects approximately 1 in 500 individuals. HCM is characterized by thickening of the heart muscle (hypertrophy) in the main pumping chamber of the heart. HCM is also associated with risk of sudden death and is the most common cause of sudden death in young athletes. Genetic mutations are commonly found in proteins of the sarcomere, which is the fundamental unit of contraction in a heart cell.
In the era of genetic testing, current practices have led to screening protocols for family members of affected individuals, leading to the recognition of individuals who carry the gene but have not yet shown clinical manifestations of their disease. Study of these individuals has demonstrated early contractile changes prior to obvious hypertrophy. Despite our ability to detect affected individuals and associated causative genes, our understanding of how sarcomeric mutations lead to HCM is incomplete, and we lack therapies aimed at halting or slowing the progression of HCM in individuals who carry the mutations.
Our goal is to investigate how individual sarcomeric mutations lead to unique alterations in contractile properties, at the level of contractile proteins and proteins that handle calcium in the cell ( the main catalyst for initiating contraction). We will do this by studying the functional characteristics of heart cells that are obtained from patients with HCM who are undergoing cardiac surgery as a result of their disease.
It is our hope that by increasing our understanding of the molecular mechanisms that contribute to the development of HCM, we will be able to design effective strategies that will halt or slow the progression of HCM.
Programme
Banting Postdoctoral Fellowship Program
Bénéficiaire
Emplacement
Illinois, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
296987
Name
Vanderlaan Rachel D
Region
Illinois
Country
United States of America
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
The role of myofilament mechanics and calcium handling in the pathogenesis of hypertrophic cardiomyopathy
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Calcium Handling; Cell Signaling And Signal Transduction; Hypertrophic Cardiomyopathy; Myocardial Energetics; Myofilament Mechanics
Abstract
Hypertrophic cardiomyopathy (HCM) is a genetic disorder of heart muscle and affects approximately 1 in 500 individuals. HCM is characterized by thickening of the heart muscle (hypertrophy) in the main pumping chamber of the heart. HCM is also associated with risk of sudden death and is the most common cause of sudden death in young athletes. Genetic mutations are commonly found in proteins of the sarcomere, which is the fundamental unit of contraction in a heart cell.
In the era of genetic testing, current practices have led to screening protocols for family members of affected individuals, leading to the recognition of individuals who carry the gene but have not yet shown clinical manifestations of their disease. Study of these individuals has demonstrated early contractile changes prior to obvious hypertrophy. Despite our ability to detect affected individuals and associated causative genes, our understanding of how sarcomeric mutations lead to HCM is incomplete, and we lack therapies aimed at halting or slowing the progression of HCM in individuals who carry the mutations.
Our goal is to investigate how individual sarcomeric mutations lead to unique alterations in contractile properties, at the level of contractile proteins and proteins that handle calcium in the cell ( the main catalyst for initiating contraction). We will do this by studying the functional characteristics of heart cells that are obtained from patients with HCM who are undergoing cardiac surgery as a result of their disease.
It is our hope that by increasing our understanding of the molecular mechanisms that contribute to the development of HCM, we will be able to design effective strategies that will halt or slow the progression of HCM.
Competitiondate
201310
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Vanderlaan, Rachel D
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~